These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 23814319)

  • 1. PHS guideline for reducing human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ;
    Public Health Rep; 2013 Jul; 128(4):247-343. PubMed ID: 23814319
    [No Abstract]   [Full Text] [Related]  

  • 2. Excerpt from PHS guideline for reducing HIV, HBV and HCV transmission through organ transplantation.
    Seem DL; Lee I; Umscheid CA; Kuehnert MJ
    Am J Transplant; 2013 Aug; 13(8):1953-62. PubMed ID: 23890284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection - U.S. Public Health Service Guideline, 2020.
    Jones JM; Kracalik I; Levi ME; Bowman JS; Berger JJ; Bixler D; Buchacz K; Moorman A; Brooks JT; Basavaraju SV
    MMWR Recomm Rep; 2020 Jun; 69(4):1-16. PubMed ID: 32584804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deceased Organ Donors and PHS Risk Identification: Impact on Organ Usage and Outcomes.
    Pruett TL; Clark MA; Taranto SE
    Transplantation; 2017 Jul; 101(7):1670-1678. PubMed ID: 28252560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Utilization of increased risk for transmission of infectious disease donor organs in solid organ transplantation: Retrospective analysis of disease transmission and safety.
    Irwin L; Kotton CN; Elias N; Palafox J; Basler D; Shao SH; Lester W; Zhang X; Kimball B; Trencher C; Fishman JA
    Transpl Infect Dis; 2017 Dec; 19(6):. PubMed ID: 28994164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantifying the risk of undetected HIV, hepatitis B virus, or hepatitis C virus infection in Public Health Service increased risk donors.
    Jones JM; Gurbaxani BM; Asher A; Sansom S; Annambhotla P; Moorman AC; Kamili S; Brooks JT; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2583-2593. PubMed ID: 30980600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year.
    Volk ML; Wilk AR; Wolfe C; Kaul DR
    Transplantation; 2017 Jul; 101(7):1666-1669. PubMed ID: 28196048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ transplantation from "increased infectious risk donors": the experience of the Nord Italia Transplant program - A retrospective study.
    Grossi PA; Dalla Gasperina D; Lombardi D; Ricci A; Piccolo G; Nanni Costa A
    Transpl Int; 2018 Feb; 31(2):212-219. PubMed ID: 29057524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of US Public Health Service increased risk deceased donor designation on organ utilization.
    Sapiano MRP; Jones JM; Bowman J; Levi ME; Basavaraju SV
    Am J Transplant; 2019 Sep; 19(9):2560-2569. PubMed ID: 30959569
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Public health safety and transplant with increased-risk organs: striking the balance.
    Batra R; Katariya N; Hewitt W; Mathur A; Reddy S; Moss A; Segev D; Singer A
    Exp Clin Transplant; 2015 Apr; 13 Suppl 1():9-12. PubMed ID: 25894120
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventing the transmission of bloodborne pathogens in health care and public service settings.
    Can Commun Dis Rep; 1997 May; 23 Suppl 3():i-vii, 1-43, i-vii, 1-52. PubMed ID: 11195251
    [No Abstract]   [Full Text] [Related]  

  • 12. PHS guidelines for management of occupational exposure to HBV, HCV and HIV: management of occupational blood exposures.
    Preboth M
    Am Fam Physician; 2001 Dec; 64(12):2012-4. PubMed ID: 11775767
    [No Abstract]   [Full Text] [Related]  

  • 13. SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus.
    Henderson DK; Dembry L; Fishman NO; Grady C; Lundstrom T; Palmore TN; Sepkowitz KA; Weber DJ;
    Infect Control Hosp Epidemiol; 2010 Mar; 31(3):203-32. PubMed ID: 20088696
    [No Abstract]   [Full Text] [Related]  

  • 14. Letter in response to the new SHEA guideline for healthcare workers with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus.
    Saag MS; Squires KE; Aberg JA; Bardeguez A
    Infect Control Hosp Epidemiol; 2010 Oct; 31(10):1092-3; author reply 1093-5. PubMed ID: 20812818
    [No Abstract]   [Full Text] [Related]  

  • 15. Human immunodeficiency virus postexposure prophylaxis for medical trainees on international rotations.
    Mohan S; Sarfaty S; Hamer DH
    J Travel Med; 2010; 17(4):264-8. PubMed ID: 20636600
    [No Abstract]   [Full Text] [Related]  

  • 16. Screening recipients of increased risk donor organs: A multicenter retrospective study.
    Ison MG; Rana MM; Brizendine KD; Chimienti S; Le J; Kfoury R; Mohazabnia P; Theodoropoulos N
    Transpl Infect Dis; 2018 Jun; 20(3):e12862. PubMed ID: 29512233
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of medical and social history as prescreening to eliminate cornea donors at risk of having hepatitis B (HBV), hepatitis C (HCV), and human immunodeficiency virus (HIV).
    Davis AR
    Cornea; 1998 Jul; 17(4):457-8. PubMed ID: 9676925
    [No Abstract]   [Full Text] [Related]  

  • 18. Screening recipients of increased-risk donor organs: a survey of transplant infectious diseases physician practices.
    Theodoropoulos N; Ladner DP; Ison MG
    Transpl Infect Dis; 2013 Oct; 15(5):545-9. PubMed ID: 23901896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transmission of disease through transplantation of musculoskeletal allografts.
    Tomford WW
    J Bone Joint Surg Am; 1995 Nov; 77(11):1742-54. PubMed ID: 7593087
    [No Abstract]   [Full Text] [Related]  

  • 20. Guidelines regarding HIV and other bloodborne pathogens in vascular/interventional radiology. SCVIR Technology Assessment Committee.
    Hansen ME; Bakal CW; Dixon GD; Eschelman DJ; Horton KM; Katz M; Olcott EW; Sacks D
    J Vasc Interv Radiol; 1997; 8(4):667-76. PubMed ID: 9232587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 22.